UBS Group »

Homology Medicines shares owned by UBS Group

Quarter-by-quarter ownership of Homology Medicines shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Homology Medicines

Tip: Access up to 7 years of quarterly data

All positions including Homology Medicines held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Homology Medicines by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.3k 14k 0.61
2023-09-30 $17k 15k 1.17
2023-06-30 $15k 16k 0.88
2023-03-31 $12k 11k 1.03
2022-12-31 $18k 14k 1.26
2022-09-30 $54k 33k 1.62
2022-06-30 $375k 190k 1.97
2022-03-31 $74k 24k 3.03
2021-12-31 $129k 35k 3.65
2021-09-30 $100k 13k 8.00
2021-06-30 $30k 4.2k 7.20
2021-03-31 $1.0M 111k 9.41
2020-12-31 $1.2M 105k 11.29
2020-09-30 $1.0M 94k 10.70
2020-03-31 $137k 8.8k 15.49
2019-12-31 $41k 2.0k 20.50
2019-09-30 $882k 49k 18.11
2019-06-30 $168k 8.6k 19.55
2019-03-31 $42k 1.5k 28.00
2018-12-31 $25k 1.1k 22.00
2018-09-30 $66k 3.0k 22.00
2018-06-30 $35k 1.7k 20.54